In partnership with the Rivkin Center for Ovarian Cancer Research, CARE Fund’s Board of Directors is pleased to announce the 2025 Rivkin Center/CARE Fund Awards recipients. The Rivkin Center/CARE Fund Awards are a first-of-its-kind public-private partnership to invest $1M in ovarian cancer research in Washington.

The 2025 Rivkin Center/CARE Fund awardees are described below:

• Mary L. “Nora” Disis, MD, University of Washington, a vaccine to prevent ovarian cancer metastatic spread
• Megan Shen, PhD, Fred Hutchinson Cancer Center, adaptation of Helping Ovarian Cancer Patients Cope (HOPE) for Clinician Burnout

These awards exemplify the shared dedication of CARE Fund and the Rivkin Center to invest in research that has the potential to significantly enhance understanding, prevention, detection, and treatment of ovarian cancer.

“Both the Rivkin Center and CARE Fund remain committed to advancing cancer research. By working together to fund ovarian cancer studies in Washington State, we are continuing to build on that legacy. The discoveries made through this partnership will have a lasting impact on families, friends, and communities,” said Dr. Elizabeth Lawlor, Chair of the CARE Board of Directors.

“Through our partnership with the CARE Fund and with the help of donors committed to scientific research, we have made an unprecedented investment in ovarian cancer research in Washington State to help get the answers we need to save more lives,” said Rivkin Center CEO, Molly O’Connor. “We’re incredibly fortunate to have such innovative leaders in ovarian cancer research right here in our state.”

On April 1, 2025, the Rivkin Center will combine with the Ovarian Cancer Research Alliance (OCRA), a national grantmaker investing in ovarian and gynecologic cancer research. The CARE Board looks forward to future opportunities for collaboration that will positively impact cancer research and improve patient outcomes for all Washingtonians.